A detailed history of Fil LTD transactions in Dexcom Inc stock. As of the latest transaction made, Fil LTD holds 239,931 shares of DXCM stock, worth $18.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
239,931
Previous 239,695 0.1%
Holding current value
$18.1 Million
Previous $27.2 Million 40.83%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $15,104 - $27,390
236 Added 0.1%
239,931 $16.1 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $5.73 Million - $7.3 Million
51,975 Added 27.69%
239,695 $27.2 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $155,110 - $190,255
1,358 Added 0.73%
187,720 $26 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $7.72 Million - $12.7 Million
102,213 Added 121.47%
186,362 $23.1 Million
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $1.74 Million - $2.79 Million
-20,216 Reduced 19.37%
84,149 $7.85 Million
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $389,933 - $454,107
-3,467 Reduced 3.22%
104,365 $13.4 Million
Q1 2023

May 11, 2023

SELL
$104.0 - $122.92 $363,480 - $429,605
-3,495 Reduced 3.14%
107,832 $12.5 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $8.21 Million - $11.9 Million
-96,621 Reduced 46.46%
111,327 $12.6 Million
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $5.76 Million - $7.1 Million
-75,439 Reduced 26.62%
207,948 $16.7 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $12.4 Million - $24.3 Million
182,954 Added 182.17%
283,387 $21.1 Million
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $9.45 Million - $13.1 Million
100,433 New
100,433 $51.4 Million
Q2 2021

Aug 13, 2021

SELL
$80.99 - $107.93 $242 - $323
-3 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$78.0 - $104.5 $78 - $104
-1 Reduced 25.0%
3 $1,000
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $250 - $421
4 New
4 $2,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.